209 related articles for article (PubMed ID: 25440150)
1. Systemic inflammatory response and survival in patients undergoing curative resection of oral squamous cell carcinoma.
Farhan-Alanie OM; McMahon J; McMillan DC
Br J Oral Maxillofac Surg; 2015 Feb; 53(2):126-31. PubMed ID: 25440150
[TBL] [Abstract][Full Text] [Related]
2. Systemic inflammatory response in predicting outcomes of patients undergoing curative resection for oral squamous cell carcinoma.
Zubair F; McMahon J; Kryklyas G; Wicks C
Br J Oral Maxillofac Surg; 2022 Jun; 60(5):589-595. PubMed ID: 35248409
[TBL] [Abstract][Full Text] [Related]
3. The preoperative sensitive-modified Glasgow prognostic score is superior to the modified Glasgow prognostic score in predicting long-term survival for esophageal squamous cell carcinoma.
Tian R; Zhang F; Sun P; Wu J; Yan H; Wu AR; Zhang M; Jiang YL; Lu YH; Xu QY; Zhan XH; Zhang RX; Qian LT; He J
Oncotarget; 2016 Oct; 7(41):67485-67494. PubMed ID: 27528228
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of the role of inflammation in renal cancer.
Qayyum T; McArdle PA; Lamb GW; Going JJ; Orange C; Seywright M; Horgan PG; Oades G; Aitchison MA; Edwards J
Urol Int; 2012; 88(3):277-81. PubMed ID: 22377628
[TBL] [Abstract][Full Text] [Related]
5. Risk stratification in oral cavity squamous cell carcinoma by preoperative CRP and SCC antigen levels.
Huang SF; Wei FC; Liao CT; Wang HM; Lin CY; Lo S; Huang JJ; Chen IH; Kang CJ; Chien HT; Chen HH
Ann Surg Oncol; 2012 Nov; 19(12):3856-64. PubMed ID: 22576068
[TBL] [Abstract][Full Text] [Related]
6. Refining the role of preoperative C-reactive protein by neutrophil/lymphocyte ratio in oral cavity squamous cell carcinoma.
Fang HY; Huang XY; Chien HT; Chang JT; Liao CT; Huang JJ; Wei FC; Wang HM; Chen IH; Kang CJ; Huang SF
Laryngoscope; 2013 Nov; 123(11):2690-9. PubMed ID: 23619955
[TBL] [Abstract][Full Text] [Related]
7. The inflammation-based modified Glasgow Prognostic Score in patients with vulvar cancer.
Hefler-Frischmuth K; Seebacher V; Polterauer S; Tempfer C; Reinthaller A; Hefler L
Eur J Obstet Gynecol Reprod Biol; 2010 Mar; 149(1):102-5. PubMed ID: 20080329
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the prognostic value of tumour- and patient-related factors in patients undergoing potentially curative resection of oesophageal cancer.
Dutta S; Crumley AB; Fullarton GM; Horgan PG; McMillan DC
World J Surg; 2011 Aug; 35(8):1861-6. PubMed ID: 21538187
[TBL] [Abstract][Full Text] [Related]
9. The glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma.
La Torre M; Nigri G; Cavallini M; Mercantini P; Ziparo V; Ramacciato G
Ann Surg Oncol; 2012 Sep; 19(9):2917-23. PubMed ID: 22488099
[TBL] [Abstract][Full Text] [Related]
10. A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study.
Proctor MJ; Morrison DS; Talwar D; Balmer SM; Fletcher CD; O'Reilly DS; Foulis AK; Horgan PG; McMillan DC
Eur J Cancer; 2011 Nov; 47(17):2633-41. PubMed ID: 21724383
[TBL] [Abstract][Full Text] [Related]
11. Changes in modified Glasgow prognostic score after neoadjuvant chemotherapy is a prognostic factor in clinical stage II/III esophageal cancer.
Otowa Y; Nakamura T; Takiguchi G; Tomono A; Yamamoto M; Kanaji S; Imanishi T; Suzuki S; Tanaka K; Itoh T; Kakeji Y
Dis Esophagus; 2016; 29(2):146-51. PubMed ID: 25515972
[TBL] [Abstract][Full Text] [Related]
12. Systemic inflammation predicts all-cause mortality: a glasgow inflammation outcome study.
Proctor MJ; McMillan DC; Horgan PG; Fletcher CD; Talwar D; Morrison DS
PLoS One; 2015; 10(3):e0116206. PubMed ID: 25730322
[TBL] [Abstract][Full Text] [Related]
13. Optimization of the systemic inflammation-based Glasgow prognostic score: a Glasgow Inflammation Outcome Study.
Proctor MJ; Horgan PG; Talwar D; Fletcher CD; Morrison DS; McMillan DC
Cancer; 2013 Jun; 119(12):2325-32. PubMed ID: 23575969
[TBL] [Abstract][Full Text] [Related]
14. The prognostic and staging implications of bone invasion in oral squamous cell carcinoma.
Ebrahimi A; Murali R; Gao K; Elliott MS; Clark JR
Cancer; 2011 Oct; 117(19):4460-7. PubMed ID: 21437887
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil:lymphocyte ratio as a simple and novel biomarker for prediction of locoregional recurrence after chemoradiotherapy for squamous cell carcinoma of the anus.
Toh E; Wilson J; Sebag-Montefiore D; Botterill I
Colorectal Dis; 2014 Mar; 16(3):O90-7. PubMed ID: 24148256
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the prognostic value of inflammation-based pathologic and biochemical criteria in patients undergoing potentially curative resection for colorectal cancer.
Roxburgh CS; Salmond JM; Horgan PG; Oien KA; McMillan DC
Ann Surg; 2009 May; 249(5):788-93. PubMed ID: 19387324
[TBL] [Abstract][Full Text] [Related]
17. The modified Glasgow prognostic score in patients undergoing surgery for bone and soft tissue sarcoma.
Morhij R; Mahendra A; Jane M; McMillan DC
J Plast Reconstr Aesthet Surg; 2017 May; 70(5):618-624. PubMed ID: 28342782
[TBL] [Abstract][Full Text] [Related]
18. Serum C-reactive protein as a prognostic indicator in patients with oral squamous cell carcinoma.
Khandavilli SD; Ceallaigh PO; Lloyd CJ; Whitaker R
Oral Oncol; 2009 Oct; 45(10):912-4. PubMed ID: 19502100
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of pre-treatment circulating monocyte count in patients with cervical cancer: comparison with SCC-Ag level.
Lee YY; Choi CH; Sung CO; Do IG; Huh S; Song T; Kim MK; Kim HJ; Kim TJ; Lee JW; Kim BG; Bae DS
Gynecol Oncol; 2012 Jan; 124(1):92-7. PubMed ID: 22014631
[TBL] [Abstract][Full Text] [Related]
20. The value of inflammation based prognostic scores in patients undergoing surgical resection for oesophageal and gastric carcinoma.
Wen J; Bedford M; Begum R; Mitchell H; Hodson J; Whiting J; Griffiths E
J Surg Oncol; 2018 Jun; 117(8):1697-1707. PubMed ID: 29761518
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]